Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SOLESENCE, INC.NANX · Entity 7041 | Chief Financial Officer | March 26, 2018 | March 28, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SOLESENCE, INC.
Report date March 26, 2018 · Filed March 28, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.44 · Expires 2028-03-26 | Direct | 36,000 |
Reported balance
After 2018-03-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-03-26 · Grant · Acquired 36,000 · Balance 36,000 F1: Vests in three equal annual installments commencing on March 26, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: Vests in three equal annual installments commencing on March 26, 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 26, 2018 Filed Mar 28, 2018 23:48 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantEmployee Stock Option (right to buy) · Derivative | 36,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0000911916-18-000089 · edgar.xml · derivative · entry 1 ESCOBAR JAIME · CIK 0001735825 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Underlying: Common Stock · 36,000 shares Expires 2028-03-26 F1 · derivative.exercise_date: Vests in three equal annual installments commencing on March 26, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.